412. O’Brien R.J. The need new drugs against tuberculosis. Obstacles,
opportunisties, and next steps / R.J. O’Brien, P.P. Nunn // Am. J. Resp. Crit. Care
Med. - 2 0 0 1 . -V o l . 162.- P . 1055-1058.
413. O’Hare M. Levofloxacin: low potential for cardiovascular adverse
reactions / M. O’Hare, I.N. Simpson // Clin. Microb. Inf. - 2001. - № 7. - Suppl. 1.
P 852.
414. Oppenheim J. Cytokine Reference / J. Oppenheim, M. Feldman. -
London: Academic Press, 2000. - 2015 p.
415. Pablos-Mendez A. Global surveillance for antituberculosis-drug
resistance, 1994-1997 / A. Pablos-Mendez, M.C. Raviglione, A. Laszlo et al. // N.
Engl. J. Med. - 1998. - Vol. 338, № 23. - P. 1641-1649.
416. Parola D. Tollerabilita ed effecacia terapeutica della rifabutina nel
trattamento della tuberculosi pulmonare / D. Parola, D. Dell’Orso, S. Giovangioli //
Recenti Prog. Med. - 1999. - Vol. 90, № 5. - P. 254-257.
417. Paterson D.L. Risk factor for toxicity in elderly patients given
aminoglycosides once daily / D.L. Paterson, J.L. Robson, M.M. Wagner // J. Gen.
Intern. Med. - 1998.-V o l. 13, № 11.- P . 645-646.
418. Perez-Guzman C. Does aging modify pulmonary Tubarculosis?: a
meta-analytical review / C. Perez-Guzman, M.H. Vargas, A. Torres-Cruz et al. //
Chest. - 1999. - Vol. 116, № 4. - P. 961 -967.
419. Podemski R. Zmiany wzrokowych potencjalow wywolanych u chorych
leczonych ethambutolem / R. Podemski, A. Brzeska // Pneumol. Pjl. - 1983. - Vol.
51, № 4. - P. 247-252.
420. Poisingnon G. Reemergence of tuberculosis and socioeconomic
uncertainty / G. Poisingnon [et al.] // Rev. Med. Interne. - 1998. - Vol. 19, № 9. -
P 6 4 9 -6 5 7 .
421. Protein measurement with the Folin phenol reagent / O.H. Lowery [et
al.] // J. Biol. C hem .- 1951.-V o l. 1 9 3 .-№ l . - P . 265-275.
422. Raviglione M.C. The global epidemiology of tuberculosis / M.C.
Raviglione // Int. J. Tuberc. Lung Dis. - 2001. - Vol. 5, № 11. - P. 7-8.
401
